| 1 |
Xia H, Wu Y, Zhao J, Cheng C, Lin J, Yang Y, Lu L, Xiang Q, Bian T, Liu Q. N6-Methyladenosine-modified circSAV1 triggers ferroptosis in COPD through recruiting YTHDF1 to facilitate the translation of IREB2. Cell Death Differ 2023. [PMID: 36828914 DOI: 10.1038/s41418-023-01138-9] [Reference Citation Analysis]
|
| 2 |
Chiba Y, Adachi Y, Ando Y, Fujii S, Suto W, Sakai H. A lncRNA MALAT1 is a positive regulator of RhoA protein expression in bronchial smooth muscle cells. Life Sci 2023;313:121289. [PMID: 36529281 DOI: 10.1016/j.lfs.2022.121289] [Reference Citation Analysis]
|
| 3 |
Qiao X, Ding Y, Wu D, Zhang A, Yin Y, Wang Q, Wang W, Kang J. The roles of long noncoding RNA-mediated macrophage polarization in respiratory diseases. Front Immunol 2022;13:1110774. [PMID: 36685535 DOI: 10.3389/fimmu.2022.1110774] [Reference Citation Analysis]
|
| 4 |
Albano GD, Gagliardo R, Montalbano AM, Profita M. Non-Coding RNAs in Airway Diseases: A Brief Overview of Recent Data. Cancers (Basel) 2022;15. [PMID: 36612051 DOI: 10.3390/cancers15010054] [Reference Citation Analysis]
|
| 5 |
Zhu Y, Han Y, Almuntashiri S, Dutta S, Wang X, Owen CA, Zhang D. Dysregulation of miR-103a Mediates Cigarette Smoking-induced Lipid-laden Macrophage Formation. Am J Respir Cell Mol Biol 2022;67:695-707. [PMID: 36066909 DOI: 10.1165/rcmb.2022-0202OC] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
Li Z, Li K, Mu S, Wang Z, Di Y. Long-chain non-coding RNA MALAT1 upregulates the MMP-2 signaling pathway by inhibiting miR-106a-5p in murine oxygen- induced retinopathy.. [DOI: 10.21203/rs.3.rs-2125896/v1] [Reference Citation Analysis]
|
| 7 |
Wang Q, Chen C, Xu X, Shu C, Cao C, Wang Z, Fu Y, Xu L, Xu K, Xu J, Xia A, Wang B, Xu G, Zou X, Su R, Kang W, Xue Y, Mo R, Sun B, Wang S. APAF1-Binding Long Noncoding RNA Promotes Tumor Growth and Multidrug Resistance in Gastric Cancer by Blocking Apoptosome Assembly. Adv Sci (Weinh) 2022;:e2201889. [PMID: 35975461 DOI: 10.1002/advs.202201889] [Reference Citation Analysis]
|
| 8 |
Du Y, Ding Y, Shi T, He W, Mei Z, Feng X, Zhang X, Jie Z. Suppression of circXPO1 attenuates cigarette smoke-induced inflammation and cellular senescence of alveolar epithelial cells in chronic obstructive pulmonary disease. Int Immunopharmacol 2022;111:109086. [PMID: 35907337 DOI: 10.1016/j.intimp.2022.109086] [Reference Citation Analysis]
|
| 9 |
Gao J, Xia Z, Vohidova D, Joseph J, Luo JN, Joshi N. Progress in non-viral localized delivery of siRNA therapeutics for pulmonary diseases. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.07.010] [Reference Citation Analysis]
|
| 10 |
Zhang C, Kang Y, Kong F, Yang Q, Chang D. Hotspots and development frontiers of circRNA based on bibliometric analysis. Non-coding RNA Research 2022;7:77-88. [DOI: 10.1016/j.ncrna.2022.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Yang YC, Zhang MY, Liu JY, Jiang YY, Ji XL, Qu YQ. Identification of Ferroptosis-Related Hub Genes and Their Association with Immune Infiltration in Chronic Obstructive Pulmonary Disease by Bioinformatics Analysis. Int J Chron Obstruct Pulmon Dis 2022;17:1219-36. [PMID: 35637927 DOI: 10.2147/COPD.S348569] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Xu Y, Harinck L, Lokras AG, Gerde P, Selg E, Sjöberg CO, Franzyk H, Thakur A, Foged C. Leucine improves the aerosol performance of dry powder inhaler formulations of siRNA-loaded nanoparticles. Int J Pharm 2022;:121758. [PMID: 35483619 DOI: 10.1016/j.ijpharm.2022.121758] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 13 |
Lim CL, Raju CS, Mahboob T, Kayesth S, Gupta KK, Jain GK, Dhobi M, Nawaz M, Wilairatana P, de Lourdes Pereira M, Patra JK, Paul AK, Rahmatullah M, Nissapatorn V. Precision and Advanced Nano-Phytopharmaceuticals for Therapeutic Applications. Nanomaterials (Basel) 2022;12:238. [PMID: 35055257 DOI: 10.3390/nano12020238] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 14 |
Wang Y, Wang X, Wang YX, Ma Y, Di Y. The Long-Noncoding RNA TUG1 Regulates Oxygen-Induced Retinal Neovascularization in Mice via MiR-299. Invest Ophthalmol Vis Sci 2022;63:37. [PMID: 35084431 DOI: 10.1167/iovs.63.1.37] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 15 |
Gedefaw L, Ullah S, Lee TMH, Yip SP, Huang CL. Targeting Inflammasome Activation in COVID-19: Delivery of RNA Interference-Based Therapeutic Molecules. Biomedicines 2021;9:1823. [PMID: 34944639 DOI: 10.3390/biomedicines9121823] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Wang C, Wang Z, Zhang L, Lin X. MiR-29c inhibits the metastasis of oral squamous cell carcinoma and promotes its cell cycle arrest by targeting SERPINH1. Ann Transl Med 2021;9:1423. [PMID: 34733975 DOI: 10.21037/atm-21-3720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 17 |
Artzy-Schnirman A, Arber Raviv S, Doppelt Flikshtain O, Shklover J, Korin N, Gross A, Mizrahi B, Schroeder A, Sznitman J. Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics. Adv Drug Deliv Rev 2021;176:113901. [PMID: 34331989 DOI: 10.1016/j.addr.2021.113901] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 18 |
Jain A, Prajapati SK, Tripathi M, Raichur AM, Kanwar JR. Exploring the room for repurposed hydroxychloroquine to impede COVID-19: toxicities and multipronged combination approaches with pharmaceutical insights. Expert Rev Clin Pharmacol 2021;14:715-34. [PMID: 33769888 DOI: 10.1080/17512433.2021.1909473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Zhou F, Cao C, Chai H, Hong J, Zhu M. Circ-HACE1 Aggravates Cigarette Smoke Extract-Induced Injury in Human Bronchial Epithelial Cells via Regulating Toll-Like Receptor 4 by Sponging miR-485-3p. Int J Chron Obstruct Pulmon Dis 2021;16:1535-47. [PMID: 34103911 DOI: 10.2147/COPD.S304859] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 20 |
Ding L, Tang S, Wyatt TA, Knoell DL, Oupický D. Pulmonary siRNA delivery for lung disease: Review of recent progress and challenges. J Control Release 2021;330:977-91. [PMID: 33181203 DOI: 10.1016/j.jconrel.2020.11.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 21 |
Xu Y, Thakur A, Zhang Y, Foged C. Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects. Pharmaceutics 2021;13:177. [PMID: 33525500 DOI: 10.3390/pharmaceutics13020177] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 22 |
Wang N, Wang Q, Du T, Gabriel ANA, Wang X, Sun L, Li X, Xu K, Jiang X, Zhang Y. The Potential Roles of Exosomes in Chronic Obstructive Pulmonary Disease. Front Med (Lausanne) 2020;7:618506. [PMID: 33521025 DOI: 10.3389/fmed.2020.618506] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 23 |
Xue M, Peng N, Zhu X, Zhang H. Hsa_circ_0006872 promotes cigarette smoke-induced apoptosis, inflammation and oxidative stress in HPMECs and BEAS-2B cells through the miR-145-5p/NF-κB axis. Biochem Biophys Res Commun 2021;534:553-60. [PMID: 33248690 DOI: 10.1016/j.bbrc.2020.11.044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 24 |
Chiba Y, Matsumoto M, Hanazaki M, Sakai H. Downregulation of miR-140-3p Contributes to Upregulation of CD38 Protein in Bronchial Smooth Muscle Cells. Int J Mol Sci 2020;21:E7982. [PMID: 33121100 DOI: 10.3390/ijms21217982] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
